Using Mesenchymal Stem Cells to Treat Female Infertility: An Update on Female Reproductive Diseases

Figure 2

The derivation of the four types of MSCs and the biologic property of these MSCs. Potential mechanisms have been proposed for ovarian dysfunction and endometrial disorder therapy. Vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), leukemia inhibitory factor (LIF), transforming growth factor (TGF), B-cell lymphoma 2 (Bcl-2), and matrix metalloproteinase (MMP).